IP Library Granted Patent US 11,871,984
Granted Patent B2
US 11,871,984 · App. 14/793,591 · Granted Jan 16, 2024

Systems and methods for female contraception

Inventor: Csaba Truckai (Saratoga, CA)
Assignee: Meditrina, Inc.
A61B18/1492A61B17/12031A61B17/12159A61B17/42A61F6/22A61B17/320016A61B18/02A61B2017/320791A61B2017/4233A61B2018/0022A61B2018/00291A61B2018/00559A61B2018/00577A61B2018/00607A61B2018/00702A61B2018/00791A61B2018/00875A61B2018/00886A61B2218/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,871,984
App. No.
14/793,591
Granted
Jan 16, 2024
Kind
B2
Abstract

The present invention relates to medical devices and methods for treating and occluding a female patient's fallopian tubes to provide birth control or sterilization, where such birth control/sterilization can be short term, long term, or permanent.

Claims (23)

1. A method for occluding a fallopian tube, comprising:

advancing a probe trans-cervically to a site in the fallopian tube such that a first electrode is spaced by a gap from a second electrode in the fallopian tube;

applying energy from the first electrode and the second electrode to form an area of ablated fallopian tube tissue at the site;

actuating a cutting surface coupled to the probe and being positioned between the first electrode and the second electrode to cause a bleeding at the area of ablated fallopian tube tissue wherein the bleeding facilitates adhesion of walls of the fallopian tube to provide permanent occlusion; and

withdrawing the probe from the site in the fallopian tube.

2. The method of claim 1 wherein advancing the probe includes advancing the probe over a guidewire.

3. The method of claim 1 wherein applying energy includes at least one of applying RF energy, light energy, microwave energy, resistive heating, inductive heating or ultrasound.

4. The method of claim 1 wherein actuating the cutting surface includes actuating at least one of a sharp blade edge, an abrasive element and a sharp puncturing element.

5. The method of claim 1 further including deploying a bioabsorbable implant in the site.

6. The method of claim 1 wherein actuating the cutting surface causes the bleeding in an intermediate region of the area of ablated fallopian tube tissue.

7. The method of claim 1 , wherein the cutting surface comprises at least a first sharp cutting edge carried by a moveable outer sleeve.

8. The method of claim 7 , wherein the cutting surface is intermediate to the first electrode and the second electrode spaced apart at a working end of the probe.

9. The method of claim 7 , wherein the cutting surface includes an inner member disposed in a passageway of the moveable outer sleeve.

10. The method of claim 1 , further comprising applying suction through the probe at the site.

11. The method of claim 1 , wherein applying energy further includes terminating energy delivery in response to at least one of time, impedance, capacitance, and temperature.

12. The method of claim 1 , wherein applying energy comprises providing energy by at least one of a thermal treatment or a cryogenic treatment.

13. The method of claim 12 , wherein the thermal treatment comprises an energy source selected from a group consisting of RF energy, light energy, microwave energy, resistive heating, inductive heating and ultrasound.

14. The method of claim 1 , wherein the cutting surface includes at least one of a sharp blade edge, an abrasive element and a sharp puncturing element.

15. The method of claim 1 , wherein the probe carries an expandable balloon, the method further comprises expanding the expandable balloon at the site.

16. The method of claim 1 , further comprising deploying an implant at the site.

17. The method of claim 16 , wherein the implant comprises a biodegradable or a bioresorbable polymer.

18. The method of claim 16 , wherein the implant has at least one barb.

19. The method of claim 16 , wherein the implant is porous.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2020
From: HERMES INNOVATIONS, LLC
To: MEDITRINA, INC.
Reel/Frame 052653/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: CIRRUS TECHNOLOGIES KFT
To: HERMES INNOVATIONS, LLC
Reel/Frame 050269/0093 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2015
From: TRUCKAI, CSABA
To: CIRRUS TECHNOLOGIES KFT
Reel/Frame 036837/0227 →
Continuity (3)
Provisional Application 62021334 · Jul 7, 2014
Provisional Application 62053676 · Sep 22, 2014
Related Publication 20160030109A1 · Feb 4, 2016